Abstract:BACKGROUND:Botulinum toxin type A has been increasingly used to improve the lower face contour in masseter hypertrophy. Different dosages and injection techniques are suggested in the literature, but the ideal approach remains unclear. This study aimed to establish an objective masseter classification method for a personalized botulinum toxin type A injection protocol. METHODS:A combination of clinical palpation, B-mode ultrasound examination, and anatomical dissection studies was applied to classify the masseter regarding bulging type on clenching and muscle thickness in a normal population and in patients desiring reduction of masseter hypertrophy. Based on these findings, a tailored botulinum toxin type A injection protocol was set up and evaluated in a prospective clinical study regarding masseter thickness, facial measurements, patient satisfaction, and complications. RESULTS:A total of 504 masseters were classified into five bulging types (minimal, mono, double, triple, and excessive) and three degrees of thickness (<10 mm, 10 to 14 mm, and >14 mm). Two hundred twenty cases were treated using individualized botulinum toxin type A injection dosages (20 to 40 units) and sites (one to three per muscle); the treatment was applied in 220 cases, according to the respective classification. Masseter thickness decreased significantly, from 12.9±2.9 mm to 8.7±1.7 mm, 3 months after injection (p<0.01). The initial ratio of the widest width of the lower face to the intercanthal distance (3.3±0.18) was also significantly reduced (3.0±0.2; p<0.01). The overall patient satisfaction rate was 95.9 percent. No serious complications occurred.. CONCLUSIONS:The present study provides the scientific basis for individualized botulinum toxin type A injection for masseter hypertrophy. This protocol allowed for reduction of injection dosage and complication rates, and showed beneficial clinical effects in terms of significantly reduced masseter volume and improved lower face contour. CLINICAL QUESTION/LEVEL OF EVIDENCE:Therapeutic, IV.

Effects of Two Botulinum Toxin Type a Evaluated by Shear Wave Elastography and Electromyographic Measurements of Masseter Reduction

Effects of botulinum toxin A injection therapy with ultrasound-guided for benign masseter hypertrophy

The application of shear wave elastography in the evaluation of type A botulinum toxin injection masseter for face-lift

Reduction of masseter muscle prominence after treatment with onabotulinumtoxinA: primary results from a randomized phase 2 study

Exploring botulinum toxin's impact on masseter hypertrophy: a randomized, triple-blinded clinical trial

Classification of Masseter Hypertrophy for Tailored Botulinum Toxin Type A Treatment.

Evaluation and Selecting Indications for the Treatment of Improving Facial Morphology by Masseteric Injection of Botulinum Toxin Type A.

Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study

Prolonging the Duration of Masseter Muscle Reduction by Adjusting the Masticatory Movements after the Treatment of Masseter Muscle Hypertrophy with Botulinum Toxin Type A Injection

Occlusal Force Characteristics of Masseteric Muscles after Intramuscular Injection of Botulinum Toxin A(BTX - A)for Treatment of Temporomandibular Disorder.

Assessment of Electromyographic Changes in a Patient with Masseter Hypertrophy and Muscle Pain after Botulinum Injections: A Case Report and 5 Months Follow-up

Functional and esthetic effects of botulinum toxin injection into the masseter muscles: evaluation of 80 patients from a dermatological perspective

Botulinum Toxin Injection Technique for Reducing the Masseter Size and Enhancing the Jawline

Treatment of masseter muscle hypertrophy with botulinum toxin type A injection: A review of adverse events

An Ultrasonographic Analysis of the Deep Inferior Tendon in the Masseter Muscle: Implications for Botulinum Toxin Injections

Prospective Analysis of the Effectiveness of Targeted Botulinum Toxin Type A Injection Using an Ultrasound-Guided Single-Point Injection Technique for Lower Face Contouring

Influence of Injection of Chinese Botulinum Toxin Type A on the Histomorphology and Myosin Heavy Chain Composition of Rat Gastrocnemius Muscles.

Botulinum Toxin Type A for the Treatment of Masseter Muscle Prominence in Asian Populations.

Comparison between botulinum toxin type A injection on masseter muscle only and additional injection on anterior belly of digastric muscle in sleep bruxism patients: A clinical trial

Temporalis Muscle Changes Following Botulinum Toxin A Injections in Masseter Hypertrophy Patients: A Randomized Triple-Blinded Trial

Can Botulinum Toxin-A Contribute to Reconstructing the Physiological Homeostasis of the Masticatory Complex in Short-faced Patients during Occlusal Therapy? A Prospective Pilot Study